Primary ovarian Burkitt's lymphoma: a rare oncological problem in gynaecology: a review of literature.
Anna StepniakPiotr CzuczwarPiotr SzkodziakEwa WozniakowskaSlawomir WozniakTomasz PaszkowskiPublished in: Archives of gynecology and obstetrics (2017)
Primary ovarian BL is a rare condition, included in the entity of non-Hodgkin lymphoma. The tumour can occur uni- or bilaterally in the ovaries with major symptoms such as abdominal pain or a large abdominal mass. Differential diagnosis, based on imaging features and pathological examination of the specimens, is essential for further treatment due to various aetiology of ovarian tumours. Although most of the patients suffering from ovarian BL underwent surgery after the ovarian tumour had been detected, surgical treatment is not the treatment of choice in patients with ovarian lymphoma. The mainstay of therapy is chemotherapy without further surgery. The prognosis is better if the chemotherapy protocol is more aggressive and followed by prophylactic central nervous system chemotherapy. Nowadays, multiagent protocols are administered, which improves the survival rate.
Keyphrases
- minimally invasive
- end stage renal disease
- locally advanced
- abdominal pain
- diffuse large b cell lymphoma
- chronic kidney disease
- ejection fraction
- newly diagnosed
- high resolution
- stem cells
- acute coronary syndrome
- mesenchymal stem cells
- bone marrow
- prognostic factors
- peritoneal dialysis
- replacement therapy
- mass spectrometry
- surgical site infection
- radical prostatectomy